| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2025 | Feb 6, 2025 | Tango Therapeutics, Inc. | General Counsel | Sell | 46.3 | -5,330 | -7.47% | ✗ | $16.4K |
| Feb 6, 2024 | Feb 8, 2024 | Tango Therapeutics, Inc. | General Counsel | Sell | 46.3 | -2,776 | -5.94% | ✗ | $35K |